REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$64.13
arrow_downward
-0.84%(-0.54) 1D
Aug 4, 10:31:24 AM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
R$64.13
High
R$64.13
Low
R$64.13
Mkt. cap
77.70B
Avg. vol.
455.00
Volume
2.00
52-wk high
R$73.19
52-wk low
R$49.10
Shares outstanding
101.14M
No. of employees
15K
Open
R$64.13
High
R$64.13
Low
R$64.13
Mkt. cap
77.70B
Avg. vol.
455.00
Volume
2.00
52-wk high
R$73.19
52-wk low
R$49.10
Shares outstanding
101.14M
No. of employees
15K
News stories
From sources across the web
Trefis
·
1 day ago
7 Green Days In A Row: Regeneron Pharmaceuticals Stock Is Up 17%
Simply Wall St
·
1 day ago
Regeneron Pharmaceuticals (REGN) Posts Strong Q2 Revenue, Is The Upside Already Priced In?
TIKR.com
·
1 day ago
Regeneron Pharma Q2 Earnings: EYLEA HD Outsold EYLEA for the First Time
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com
AI content may include mistakes. Learn more